Cargando…
High Expression of IKZF2 in Malignant T Cells Promotes Disease Progression in Cutaneous T Cell Lymphoma
Cutaneous T cell lymphoma is a generally indolent disease derived from skin-homing mature T cells. However, in advanced stages, cutaneous T cell lymphoma may manifest aggressive clinical behaviour and lead to a poor prognosis. The mechanism of disease progression in cutaneous T cell lymphoma remains...
Autores principales: | XU, Bufang, LIU, Fengjie, GAO, Yumei, SUN, Jingru, LI, Yingyi, LIN, Yuchieh, LIU, Xiangjun, WEN, Yujie, YI, Shengguo, DANG, Jingyang, TU, Ping, WANG, Yang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Society for Publication of Acta Dermato-Venereologica
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9472098/ https://www.ncbi.nlm.nih.gov/pubmed/34853863 http://dx.doi.org/10.2340/actadv.v101.570 |
Ejemplares similares
-
Single-cell transcriptomics links malignant T cells to the tumor immune landscape in cutaneous T cell lymphoma
por: Liu, Xiangjun, et al.
Publicado: (2022) -
Hyperprogression of cutaneous T cell lymphoma after anti–PD-1 treatment
por: Gao, Yumei, et al.
Publicado: (2023) -
Differential molecular programs of cutaneous anaplastic large cell lymphoma and CD30-positive transformed mycosis fungoides
por: Lai, Pan, et al.
Publicado: (2023) -
Baicalein Inhibits Proliferation of Myeloma U266 Cells by Downregulating IKZF1 and IKZF3
por: Liu, Xiao-Ping, et al.
Publicado: (2018) -
Lenalidomide induces degradation of IKZF1 and IKZF3
por: Krönke, Jan, et al.
Publicado: (2014)